A few updates for you this week, first the FDA approved Tzield to delay the progression of type 1 diabetes - a big advancement for the treatment of type 1 diabetes. The FDA also approved another biosimilar to Lantus, called Rezvoglar and issued a new EUA for Kineret for COVID-19 treatment. Don’t forget to like, share, & subscribe! ENJOY!